April 7, 2025 06:26 AM EDTUpdated 06:38 AM
Cell/Gene Tx
Manufacturing

Cell and gene ther­a­py CD­MO Am­pli­fy­Bio shuts down over 's­carci­ty' of fund­ing

Anna Brown

News Reporter

An­oth­er CD­MO has been hit by the slow­down of cell and gene ther­a­py R&D.

Am­pli­fy­Bio closed its doors af­ter strug­gling for months to find in­vestor …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

New fund will pres­sure flail­ing biotechs, as in­vestor frus­tra­tion boils over

Ake­so shares new da­ta sug­gest­ing it can beat Keytru­da on sur­vival, wins Chi­na ap­proval

Mer­ck KGaA clos­es in on Spring­Works deal at $3.5B price point

Ab­b­Vie com­mits $10B to ex­pand US foot­print with the threat of tar­iffs ahead

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times